Skip to content

Study on the effect of Yinhu Jiedu decoction on acne by regulating skin flora and Th17 inflammatory pathway

Study on the effect of Yinhu Jiedu decoction on acne by regulating skin flora and Th17 inflammatory pathway

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000153
Enrollment
Unknown
Registered
2024-08-01
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Interventions

Sponsors

Beijing University of Chinese Medicine Third Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) According to the diagnostic criteria of acne in western medicine, the degree of acne was in accordance with PillSbury grading II-IV; (2) in accordance with acne intestines and stomach is hot and humid card standard syndromes of traditional Chinese medicine; (3) age 18 to 45 years old, gender not limited; (4) voluntarily participated in the case collection and cooperated with treatment, and signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) pregnancy or breast-feeding women, or have a pregnancy plan within three months; (2) patients with serious medical diseases such as cardiovascular, cerebrovascular, liver, kidney, gastrointestinal tract, hematopoietic system, endocrine system, and mental illness; (3) patients with high sensitivity constitution or known to be allergic to one of the drugs in the test or control drugs; (4) patients with occupational acne or drug-induced acneiform rash or other skin diseases that may affect the observation of the test, such as eczema, allergic dermatitis, psoriasis, lupus erythematosus, etc.; (5) given antibiotics nearly 30 days, retinoic acid, antifungal drugs, steroids and immunosuppressant drugs; Topical use of retinoic acids, antibiotics, glucocorticoids and drugs within the past 7 days; Use of oral probiotics in the past 30 days. (6) is to participate in other clinical researchers, (7) or had treatment for venous blood can't recipients, faint at the sight of puppy blood history; (8) those who were deemed unfit to participate in the trial after evaluation by the investigators. Those fulfilling any of the above conditions were excluded.

Design outcomes

Primary

MeasureTime frame
Skin physiological parameters;The Global Acne Grading System,GAGS;Safety evaluation of TCM syndrome score;Investigator's global assessment;

Secondary

MeasureTime frame
Cardiff acne disability index,CADI;Self-Rating Anxiety Scale,SAS;Quality of Life-acne (Qol-acne);

Countries

China

Contacts

Public ContactWANG Yunong

Beijing University of Chinese Medicine Third Affiliated Hospital

yunongwang@163.com138 1169 3756

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026